Zhejiang Tailin BioEngineering Co.,Ltd (300813.SZ)
CNY 18.76
(-0.11%)
CNY 18.76
(-0.11%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 37 Million CNY | -62.34% |
| 2022 | 94.15 Million CNY | 15.65% |
| 2021 | 79.01 Million CNY | 31.76% |
| 2020 | 60.04 Million CNY | 31.9% |
| 2019 | 46.87 Million CNY | -20.27% |
| 2018 | 57.12 Million CNY | 16.99% |
| 2017 | 54.58 Million CNY | 65.46% |
| 2016 | 28.6 Million CNY | 54.19% |
| 2015 | 19.21 Million CNY | 50.04% |
| 2014 | 13.01 Million CNY | -44.48% |
| 2013 | 23.09 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 7.08 Million CNY | 58.47% |
| 2024 Q3 | 9.25 Million CNY | -34.76% |
| 2024 Q1 | 6.99 Million CNY | 1476.15% |
| 2023 Q2 | 6.47 Million CNY | -64.61% |
| 2023 Q3 | -1.38 Million CNY | -121.32% |
| 2023 Q4 | 567.76 Thousand CNY | 141.11% |
| 2023 FY | - CNY | -62.34% |
| 2023 Q1 | 18.3 Million CNY | -41.14% |
| 2022 Q2 | 17.2 Million CNY | 13.09% |
| 2022 Q1 | 15.21 Million CNY | -46.86% |
| 2022 FY | - CNY | 15.65% |
| 2022 Q4 | 31.1 Million CNY | 88.21% |
| 2022 Q3 | 16.52 Million CNY | -3.95% |
| 2021 Q1 | 8.92 Million CNY | -59.74% |
| 2021 FY | - CNY | 31.76% |
| 2021 Q3 | 15.35 Million CNY | -21.73% |
| 2021 Q4 | 28.62 Million CNY | 86.49% |
| 2021 Q2 | 19.61 Million CNY | 119.79% |
| 2020 Q2 | 11.76 Million CNY | 68.97% |
| 2020 Q3 | 15.65 Million CNY | 33.07% |
| 2020 Q4 | 22.16 Million CNY | 41.61% |
| 2020 FY | - CNY | 31.9% |
| 2020 Q1 | 6.96 Million CNY | -24.14% |
| 2019 Q2 | 14.09 Million CNY | 145.79% |
| 2019 FY | - CNY | -20.27% |
| 2019 Q4 | 9.17 Million CNY | -0.56% |
| 2019 Q3 | 9.22 Million CNY | -34.52% |
| 2019 Q1 | 5.73 Million CNY | -75.72% |
| 2018 Q4 | 23.62 Million CNY | 119.67% |
| 2018 Q3 | 10.75 Million CNY | 0.0% |
| 2018 FY | - CNY | 16.99% |
| 2017 Q1 | 9.78 Million CNY | 26.73% |
| 2017 Q2 | 9.78 Million CNY | 0.0% |
| 2017 FY | - CNY | 65.46% |
| 2017 Q4 | 12.8 Million CNY | 0.0% |
| 2016 FY | - CNY | 54.19% |
| 2016 Q1 | 6.58 Million CNY | 30.59% |
| 2016 Q2 | 6.58 Million CNY | -0.0% |
| 2016 Q3 | 7.71 Million CNY | 17.11% |
| 2016 Q4 | 7.71 Million CNY | 0.0% |
| 2015 Q4 | 5.04 Million CNY | 0.0% |
| 2015 Q2 | 4.28 Million CNY | 109.49% |
| 2015 FY | - CNY | 50.04% |
| 2015 Q1 | 2.04 Million CNY | -30.0% |
| 2015 Q3 | 5.04 Million CNY | 17.67% |
| 2014 Q2 | 1.11 Million CNY | -0.0% |
| 2014 Q1 | 1.11 Million CNY | 0.0% |
| 2014 Q3 | 2.92 Million CNY | 161.86% |
| 2014 Q4 | 2.92 Million CNY | 0.0% |
| 2014 FY | - CNY | -44.48% |
| 2013 FY | - CNY | 0.0% |